Literature DB >> 9636904

Anesthesia for deep hypothermic circulatory arrest in adults: experience with the first 50 patients.

J J Appoo1, F Ralley, G Baslaim, B de Varennes.   

Abstract

OBJECTIVE: To evaluate the efficacy of a simple method of central nervous system (CNS) protection in patients undergoing deep hypothermic circulatory arrest (DHCA) lasting less than 30 minutes, for a variety of complex cardiovascular procedures.
DESIGN: A retrospective case review.
SETTING: A university teaching hospital. PARTICIPANTS: Fifty consecutive patients (25 women, 25 men) undergoing elective or emergency cardiovascular operations requiring DHCA between August 1991 and December 1996.
INTERVENTIONS: Patients underwent DHCA for a variety of surgical procedures. Neurologic protection was with thiopental, ice packs to the head, and systemic core hypothermia to a nasopharyngeal temperature (NPT) of 18 degrees to 20 degrees C.
MEASUREMENTS AND MAIN RESULTS: The mean duration of circulatory arrest was 18 +/- 10 minutes (range, 5 to 42 minutes). The mean NPT at time of arrest was 18.7 degrees +/- 1.7 degrees C. Three patients (6%) had gross CNS morbidity, one of whom died. The circulatory arrest times for these three patients were 8, 39, and 40 minutes. Perioperative mortality was 8% (n = 4). The circulatory arrest times for the patients who died were 12, 13, 23, and 39 minutes.
CONCLUSION: The anesthetic management of DHCA described is simple, effective, and safe, and can be performed in any institution that performs cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636904     DOI: 10.1016/s1053-0770(98)90002-7

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  1 in total

Review 1.  Does the use of thiopental provide added cerebral protection during deep hypothermic circulatory arrest?

Authors:  Sara Al-Hashimi; Mahvash Zaman; Paul Waterworth; Haris Bilal
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.